The Virtual Conference on Controversies on Cannabis-Based Medicines

Name: The Virtual Conference on Controversies on Cannabis-Based Medicines
Start: 2022-03-24T09:00:00+01:00
End: 2022-03-24T17:00:00+01:00
Location: Virtuelle Konferenz

24. March 2022 | 09:00 – 17:00

The conference is designed for doctors, medical professionals, scientists, clinicians, clinical investigators, methodology professionals and national cannabis agencies. The goal is to present and discuss a variety of controversial topics related to medical cannabis – from pain, inflammation or epilepsy to palliative care or neurological disorders.

The conference will consist of pre-recorded lectures followed by live panel discussions with the speakers. The presentations and panel discussions are only available to registered and confirmed users. To participate, interested professionals must first register via the conference homepage “Virtual Conference on Controversies on Cannabis-Based Medicines.” (https://vmed-cannabis.com) All registered participants will receive an invitation with a personal link by e-mail. This link can be used to set up a profile and enter the virtual conference platform. The personal link is only valid until the end of the conference.

The virtual conference will be held in English and will focus its content on the following key areas:

cannabis-based medicines for the treatment of pediatric indications
cannabis-based medicines in the context of cancer (from supportive care to potential anti-tumor effects)
pros and cons of cannabis-based medicines in dementia and other neuropsychiatric disorders

Details

09:00 CET	Conference Opening & Welcome Prof. Dr. med. Sven Gottschling , Conference Chair
09:10 CET	Session 1: CANCER
09:10-09:30	Cannabinoids in Cancer
09:30-09:50	The Endocannabinoid System: A Target for Cancer Treatment
09:50-10:10	Roles of Cannabinoids in Melanoma: Evidence from in Vivo Studies
10:10-10:30	CBD and Glioma Rudolf Likar Klagenfurt Clinic, Austria
10:30 CET	Session 2: CHILDREN
10:30-10:50	Cannabinoids in children, an overview
10:50-11:10	Cannabinoids in pediatric epilepsy Kerstin Alexandra Klotz Freiburg University Medical Center, Germany
11:10-11:30	The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology
11:30 CET	LIVE Panel Discussion/Q&A with morning speakers
12:00 CET	Session 3: PSYCHIATRIC DISORDERS
12:00-12:20	Cannabinoids for psychiatric disorders – an overview
12:20-12:40	Cannabinoids Tourette Kirsten Müller-Vahl Hannover Medical School, Germany
12:40-13:00	CBD in generalized social anxiety disorder
13:00 CET	LIVE Satellite Sponsored Symposium
13:40 CET	Session 4: TOPICAL CANNABINOIDS
13:40-14:00	The potential role of cannabinoids in dermatology
14:00-14:20	Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study Nicholas Schräder University of Groningen, Germany
14:20-14:40	Cannabinoids for the treatment of chronic pruritus: A review
14:40 CET	Session 5: MIXED
14:40-15:00	Medical Cannabis and driving
15:00-15:20	Cannabinoids for the treatment of dementia
15:20-15:40	Cannabinoids in the treatment of Rheumatic disorders Winfried Häuser Klinikum Saarbrücken, Germany
15:40 CET	LIVE Panel Discussion/Q&A with afternoon speakers
16:30 CET	Closing Remarks Prof. Dr. med. Sven Gottschling , Conference Chair